Vivek Subbiah: Now that we have landed in the moon off to Mars
Vivek Subbiah shared a post on X:
”To the moon! Huge congratulations to Toni Choueiri for The Lancet and The New England Journal of Medicine paper at ESMO24! Now that we have landed in the moon – off to Mars! Exhilarating discussions about one of the greatest oncology meetings ever with Toni Choueiri, Sumanta K. Pal. Stay tuned.”
Source: Vivek Subbiah/X
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023